Cargando…

Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma

Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrar...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Han, Yu, Chen, Shizhu, Liu, Jingjie, Wang, Dajiang, Huang, Yifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214327/
https://www.ncbi.nlm.nih.gov/pubmed/35755292
http://dx.doi.org/10.1016/j.apsb.2021.10.009
_version_ 1784730990206255104
author Liu, Ying
Han, Yu
Chen, Shizhu
Liu, Jingjie
Wang, Dajiang
Huang, Yifei
author_facet Liu, Ying
Han, Yu
Chen, Shizhu
Liu, Jingjie
Wang, Dajiang
Huang, Yifei
author_sort Liu, Ying
collection PubMed
description Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrared light, it is difficult to promote and apply in clinical practice. The eye is the only transparent tissue in human, and infrared light can easily penetrate the eye tissue, so it is expected that photothermal therapy can be used to treat fundus diseases. Here in, a new nano-platform assembled by liposome and indocyanine green (ICG) was used to treat retinoblastoma. ICG was assembled in liposomes to overcome some problems of ICG itself. For example, ICG is easily quenched, self-aggregating and instability. Moreover, liposomes can prevent free ICG from being cleared through the systemic circulation. The construction of the nano-platform not only ensured the stability of ICG in vivo, but also realized imaging-guide photothermal therapy, which created a new strategy for the treatment of retinoblastoma.
format Online
Article
Text
id pubmed-9214327
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92143272022-06-23 Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma Liu, Ying Han, Yu Chen, Shizhu Liu, Jingjie Wang, Dajiang Huang, Yifei Acta Pharm Sin B Original Article Photothermal therapy has the characteristics of minimal invasiveness, controllability, high efficiency, and strong specificity, which can effectively make up for the toxic side effects and tumor resistance caused by traditional drug treatment. However, due to the limited tissue penetration of infrared light, it is difficult to promote and apply in clinical practice. The eye is the only transparent tissue in human, and infrared light can easily penetrate the eye tissue, so it is expected that photothermal therapy can be used to treat fundus diseases. Here in, a new nano-platform assembled by liposome and indocyanine green (ICG) was used to treat retinoblastoma. ICG was assembled in liposomes to overcome some problems of ICG itself. For example, ICG is easily quenched, self-aggregating and instability. Moreover, liposomes can prevent free ICG from being cleared through the systemic circulation. The construction of the nano-platform not only ensured the stability of ICG in vivo, but also realized imaging-guide photothermal therapy, which created a new strategy for the treatment of retinoblastoma. Elsevier 2022-06 2021-10-22 /pmc/articles/PMC9214327/ /pubmed/35755292 http://dx.doi.org/10.1016/j.apsb.2021.10.009 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Liu, Ying
Han, Yu
Chen, Shizhu
Liu, Jingjie
Wang, Dajiang
Huang, Yifei
Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
title Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
title_full Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
title_fullStr Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
title_full_unstemmed Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
title_short Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
title_sort liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214327/
https://www.ncbi.nlm.nih.gov/pubmed/35755292
http://dx.doi.org/10.1016/j.apsb.2021.10.009
work_keys_str_mv AT liuying liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma
AT hanyu liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma
AT chenshizhu liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma
AT liujingjie liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma
AT wangdajiang liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma
AT huangyifei liposomebasedmultifunctionalnanoplatformaseffectivetherapeuticsforthetreatmentofretinoblastoma